Teva Pharmaceutical Industries Ltd

Latest stories

6d
Reuters
Allergan CEO says company is 'weeks away' from closing Teva dealBrent Saunders said on Monday the company expects to close the $40.5 billion sa
Allergan CEO says company is 'weeks away' from closing Teva deal
Reuters / Posted 6 days ago
Brent Saunders said on Monday the company expects to close the $40.5 billion sale of its generic medicines portfolio to Teva Pharmaceutical Industries Ltd (TEVA.TA) in a matter of weeks, opening the door for new acquisitions. While Allergan... Read more
12d
Market Watch
AstraZeneca asthma drug shows positive resultstheir asthma with existing inhaled drugs and tablets. If approved, it will join
AstraZeneca asthma drug shows positive results
Market Watch / Posted 12 days ago
their asthma with existing inhaled drugs and tablets. If approved, it will join a crowded market: GlaxoSmithKline PLC and Teva Pharmaceutical Industries Ltd. have already launched similar treatments. Still, Astra hopes its drug will win favor... Read more
19d
The Irish Times
Allergan profit beats on strong sales of Botox and Restasisrepurchase program of up to $10 billion. The buyback follows Allergan’s agreem
Allergan profit beats on strong sales of Botox and Restasis
The Irish Times / Posted 19 days ago
repurchase program of up to $10 billion. The buyback follows Allergan’s agreement to sell its generic drug business to Teva Pharmaceutical Industries Ltd for $40.5 billion. That deal is expected to close in June. The company’s shares were up... Read more
6 related stories
19d
Channel NewsAsia
Allergan profit beats on strong sales of Botox and Restasisrepurchase program of up to US$10 billion. The buyback follows Allergan's agre
Allergan profit beats on strong sales of Botox and Restasis
Channel NewsAsia / Posted 19 days ago
repurchase program of up to US$10 billion. The buyback follows Allergan's agreement to sell its generic drug business to Teva Pharmaceutical Industries Ltd for US$40.5 billion. That deal is expected to close in June. The company's shares were up... Read more
6 related stories
19d
Market Watch
Allergan OKs $10B share buyback, sales fall shortlast month, after the Obama administration issued rules designed to stymie such
Allergan OKs $10B share buyback, sales fall short
Market Watch / Posted 19 days ago
last month, after the Obama administration issued rules designed to stymie such tax-lowering inversion deals. Meanwhile, Teva Pharmaceutical Industries Ltd. is moving ahead with plans to buy Allergan's generic drugs business for $40.5 billion,... Read more
7 related stories
20d
The Star
Higher health stocks and falling oil leave S&P 500 flatled by the health sector's 1.13% increase, while energy and materials sectors b
Higher health stocks and falling oil leave S&P 500 flat
The Star / Posted 20 days ago
led by the health sector's 1.13% increase, while energy and materials sectors both tumbled 1.25%. Allergan surged 5.98%. Teva Pharmaceutical Industries Ltd said it still expected its US$40.5 billion acquisition of Allergan's generic drug business... Read more
31 related stories
20d
TheBull
International markets roundup1.13 per cent increase, while energy and materials sectors both tumbled 1.25 pe
International markets roundup
TheBull / Posted 20 days ago
1.13 per cent increase, while energy and materials sectors both tumbled 1.25 per cent. Allergan surged 5.98 per cent. Teva Pharmaceutical Industries Ltd said it still expected its $US40.5 billion acquisition of Allergan's generic drug business... Read more
12 related stories
20d
TheBull
Wall Street ends mixed1.13 per cent increase, while energy and materials sectors both tumbled 1.25 pe
Wall Street ends mixed
TheBull / Posted 20 days ago
1.13 per cent increase, while energy and materials sectors both tumbled 1.25 per cent. Allergan surged 5.98 per cent. Teva Pharmaceutical Industries Ltd said it still expected its $US40.5 billion acquisition of Allergan's generic drug business... Read more
31 related stories
20d
The Star
Wall Street mixed as energy falls, Allergan rallies (Update 1)dropped 3%, weighing the most on the Dow industrials. Leading healthcare stock
Wall Street mixed as energy falls, Allergan rallies (Update 1)
The Star / Posted 20 days ago
dropped 3%, weighing the most on the Dow industrials. Leading healthcare stocks higher, Allergan surged 6.7% after Teva Pharmaceutical Industries Ltd said it expected its US$40.5bil acquisition of Allergan’s generic drug business to close... Read more
25 related stories
20d
FOX Business
Wall Street Mixed as Energy Falls, Allergan Rallies3 percent, weighing the most on the Dow industrials. Leading healthcare stocks
Wall Street Mixed as Energy Falls, Allergan Rallies
FOX Business / Posted 20 days ago
3 percent, weighing the most on the Dow industrials. Leading healthcare stocks higher, Allergan surged 6.7 percent after Teva Pharmaceutical Industries Ltd said it expected its $40.5 billion acquisition of Allergan's generic drug business to... Read more
25 related stories
20d
FOX Business
Wall Street Mixed as Energy Falls, Allergan Rallies3 percent, weighing the most on the Dow industrials. Leading healthcare stocks
Wall Street Mixed as Energy Falls, Allergan Rallies
FOX Business / Posted 20 days ago
3 percent, weighing the most on the Dow industrials. Leading healthcare stocks higher, Allergan surged 6.7 percent after Teva Pharmaceutical Industries Ltd said it expected its $40.5 billion acquisition of Allergan's generic drug business to... Read more
25 related stories
23d
The Irish Times
Drug company Endo’s shares drop 41% after profit forecast cutoff more than $2 billion (€1.75 billion) of market value. Shares of other spec
Drug company Endo’s shares drop 41% after profit forecast cut
The Irish Times / Posted 23 days ago
off more than $2 billion (€1.75 billion) of market value. Shares of other speciality and generic drug makers such as Teva Pharmaceutical Industries Ltd, Mylan NV and Allergan Plc were down 5-7 per cent. The US generics industry is under... Read more
24d
Channel NewsAsia
Teva Pharm finalizing asset sales to clear Allergan dealREUTERS: Teva Pharmaceutical Industries Ltd is finalizing as much as US$2 billi
Teva Pharm finalizing asset sales to clear Allergan deal
Channel NewsAsia / Posted 24 days ago
REUTERS: Teva Pharmaceutical Industries Ltd is finalizing as much as US$2 billion in asset sale agreements to win U.S. antitrust clearance for its US$40.5 billion acquisition of Allergan Plc's generic drug portfolio, according to a source familiar... Read more
24d
Reuters
Teva Pharm finalizing asset sales to clear Allergan dealTeva Pharmaceutical Industries' Jerusalem oral solid dosage plant (OSD) is seen
Teva Pharm finalizing asset sales to clear Allergan deal
Reuters / Posted 24 days ago
Teva Pharmaceutical Industries' Jerusalem oral solid dosage plant (OSD) is seen December 21, 2011. Teva Pharmaceutical Industries Ltd is finalizing as much as $2 billion in asset sale agreements to win U.S. antitrust clearance for its $40.5 billion... Read more
25d
The Jewish Journal of Greater Los Angeles
Agent of Change: The California-Israel Global Innovation Partnership [LIVE AT 2:45 PM] | LIVE BroadcastResearch Organization, Volcani Center, Ministry of Agriculture and Rural Develo
Agent of Change: The California-Israel Global Innovation Partnership [LIVE AT 2:45 PM] | LIVE Broadcast
The Jewish Journal of Greater Los Angeles / Posted 25 days ago
Research Organization, Volcani Center, Ministry of Agriculture and Rural Development, Israel Yitzhak Peterburg, Chairman, Teva Pharmaceutical Industries Ltd. In 2014, California Gov. Jerry Brown and Israeli Prime Minister Benjamin Netanyahu... Read more
25d
The Globe and Mail
Biotech stock swoon sparks buyout interest: Janus managerwill now seek smaller transactions. Allergan will be flush with cash if its $40
Biotech stock swoon sparks buyout interest: Janus manager
The Globe and Mail / Posted 25 days ago
will now seek smaller transactions. Allergan will be flush with cash if its $40-billion sale of its generics unit to Teva Pharmaceutical Industries Ltd wins U.S. antitrust approval. One potential target for Allergan, Acker said, is Ironwood... Read more
2 related stories
25d
Channel NewsAsia
Biotech stock swoon sparks buyout interest: investorwill now seek smaller transactions. Allergan will be flush with cash if its US$
Biotech stock swoon sparks buyout interest: investor
Channel NewsAsia / Posted 25 days ago
will now seek smaller transactions. Allergan will be flush with cash if its US$40 billion sale of its generics unit to Teva Pharmaceutical Industries Ltd wins U.S. antitrust approval. One potential target for Allergan, Acker said, is Ironwood... Read more
2 related stories
25d
Reuters
Biotech stock swoon sparks buyout interest: investorwill now seek smaller transactions. Allergan will be flush with cash if its $40
Biotech stock swoon sparks buyout interest: investor
Reuters / Posted 25 days ago
will now seek smaller transactions. Allergan will be flush with cash if its $40 billion sale of its generics unit to Teva Pharmaceutical Industries Ltd (TEVA.TA) wins U.S. antitrust approval. One potential target for Allergan, Acker said, is... Read more
2 related stories

People in this news